OTC Pharmaceuticals - North America (NAFTA) Industry Guide - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-04-21 12:20:02
The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The OTC pharmaceuticals industry within the NAFTA countries had a total market value of $34,302.5 million in 2012.The Mexico was the fastest growing country, with a CAGR of 5.4% over the 2008-12 period.
Within the OTC pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $28,784.9 million in 2012. This was followed by Canada and Mexico, with a value of $3,177.1 and $2,340.5 million, respectively.
The US is expected to lead the OTC pharmaceuticals industry in the NAFTA bloc, with a value of $32,123.7 million in 2017, followed by Canada and Mexico with expected values of $3,645.7 and $2,835.0 million, respectively.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.